Brucellosis in children under 8 years of age requires an age-specific antibiotic strategy. Standard regimens used in older children and adults are not appropriate for this group, making careful drug selection essential for effective treatment.
This protocol applies to paediatric patients under 8 years of age presenting with confirmed or suspected Brucellosis. The patient's age is the defining factor in treatment selection, as certain antibiotic classes routinely used in adults carry restrictions in young children.
Management in this age group is built around combination antibiotic therapy, with co-trimoxazole serving as the cornerstone agent paired with a second antibiotic. Localised forms of the infection follow the same general combination approach but require specific course-length adjustments. The complete structured regimen — including drug pairings, all clinical parameters, and guidance for localised disease — is available in the full protocol.